EUVIMEDEUVIMED entdecken
Crossref

20( S )-Protopanaxadiol Targets HMGB1 to Inhibit Inflammasome Activation and Ameliorate Acute Lung Injury

Junyao Li, Jing Li, Jiawei Dai, Jianping Hu iD, Yuhan Wang, Pengrui Yan, Honggang Wang, Weicheng Hu iD

Journal of Agricultural and Food Chemistry · 11.11.2026 · 74 (44) · 34754-34765

DOI: 10.1021/acs.jafc.6c02986 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, online erschienen am 02.11.2026. Verfasst von Junyao Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, Faculty of Medicine, Yangzhou University, Yangzhou225009, China. Hauptthemen laut MEDLINE: Acute Lung Injury, Sapogenins, HMGB1 Protein, Inflammasomes. Die Arbeit nennt 32 Literaturangaben. Gefördert von: High-end Foreign Experts Recruitment Plan of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

20(S)-Protopanaxadiol (PPD), a major intestinal metabolite of ginsenosides from Panax ginseng, possesses anti-inflammatory properties, yet its direct molecular targets are poorly defined. This study investigated the protective effects of PPD against acute lung injury (ALI) and its potential mechanism. Using LPS-challenged immortalized mouse bone-marrow-derived macrophages (iBMDMs) and ALI mouse models, limited proteolysis–mass spectrometry identified HMGB1 as the primary binding target. PPD blocked inflammasome activation and interrupted HMGB1–TLR4 interaction. Molecular docking, dynamics simulations, and site mutagenesis verified that PPD stably binds the HMGB1 B-box domain. In vivo, PPD mitigated pulmonary damage, alleviated alveolar edema and inflammatory infiltration, lowered proinflammatory cytokines, and restrained HMGB1 secretion. In conclusion, PPD directly targets HMGB1 to block HMGB1–TLR4 inflammatory signaling. These data suggest PPD can serve as a promising functional food constituent for ALI prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjurySapogeninsHMGB1 ProteinInflammasomesAnimalsMiceMacrophagesToll-Like Receptor 4HumansMice, Inbred C57BLMalePanaxMolecular Docking Simulation

Stichwörter der Autor:innen

Acute Lung InjuryHMGB1NLRP3 inflammasomeProtopanaxadiolTLR4

Substanzen

SapogeninsHMGB1 ProteinprotopanaxadiolToll-Like Receptor 4Inflammasomes

Autor:innen und Institutionen

  • School of Basic Medicine, Faculty of Medicine, Yangzhou University, Yangzhou225009, China.
  • Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, School of Pharmacy, Chengdu University, Chengdu610106, China.
  • Department of Gastroenterology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian223300, China.

ORCID-Profile: Jianping Hu, Weicheng Hu

Förderung

  • High-end Foreign Experts Recruitment Plan of China

Zitieren

APA

Li, J., Li, J., Dai, J., Hu, J., Wang, Y., Yan, P., Wang, H., & Hu, W. (2026). 20( S )-Protopanaxadiol Targets HMGB1 to Inhibit Inflammasome Activation and Ameliorate Acute Lung Injury. Journal of Agricultural and Food Chemistry, 74(44), 34754-34765. https://doi.org/10.1021/acs.jafc.6c02986

Vancouver

Li J, Li J, Dai J, Hu J, Wang Y, Yan P, et al. 20( S )-Protopanaxadiol Targets HMGB1 to Inhibit Inflammasome Activation and Ameliorate Acute Lung Injury. Journal of Agricultural and Food Chemistry. 2026;74(44):34754-34765. doi:10.1021/acs.jafc.6c02986

BibTeX
@article{Li2026,
  author = {Li, Junyao and Li, Jing and Dai, Jiawei and Hu, Jianping and Wang, Yuhan and Yan, Pengrui and Wang, Honggang and Hu, Weicheng},
  title = {20( S )-Protopanaxadiol Targets HMGB1 to Inhibit Inflammasome Activation and Ameliorate Acute Lung Injury},
  journal = {Journal of Agricultural and Food Chemistry},
  year = {2026},
  volume = {74},
  number = {44},
  pages = {34754--34765},
  doi = {10.1021/acs.jafc.6c02986}
}
Kostenlos starten →